Free Submission Public Relations &
Deutsch English


STC launches MedTech Boardroom Stimulator program

Print article Print article
2014-03-13 09:46:24 - STC (the Small Technologies Cluster) today announced the launch of ‘The MedTech Boardroom Stimulator’ program, a free mentorship program for start-ups, SMEs and larger companies developing, commercialising and selling medical technologies.

STC’s mission of growing and supporting strong innovative advanced technology companies is demonstrated in their latest program, ‘The MedTech Boardroom Stimulator.’ This is a free program for start-ups, SMEs and larger companies to access mentorship and drive more opportunity capitalisation, increased productivity and refined product development and market strategy.

These lunch sessions represent a virtual boardroom scenario where participating companies can get assistance in identifying collaborative opportunities, refine strategy and brainstorm specific challenges.

Space is limited – companies interested in participating should contact STC (

“This program was designed as a direct response to the needs and challenges we see in advanced technology companies, like medtech. It is impossible for a company to be fully networked, to be aware of all

opportunities – and threats, or to think about business strategy from every angle. Surrounding promising companies with experts will undoubtedly drive lasting benefit to the participant company, the mentors that participate, and the innovation ecosystem as a whole.” said Buzz Palmer, STC’s CEO.

The ‘MedTech Boardroom Stimulator’ is provided through support from the Victorian Government Department of State Development, Business and Innovation.

Contact Information:

1 Dalmore Drive, Melbourne (Scoresby)

Contact Person:
Laura Faulconer
Phone: +61 3 9763 4777
email: email


Laura Faulconer
Phone: 61397634777

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact